Today’s top gainers include the company Medivation, Inc. (NASDAQ:MDVN) which is in the industry Biotechnology, gaining 0.14% today. In the last week its performance is 19.64%, and 32.53% for the past quarter. Currently, Medivation, Inc., MDVN has a target price of 77.15, so today’s gain of 0.14% is a significant step towards its target price. The GAP today is therefore 0.00%.
Medivation, Inc. (NASDAQ:MDVN), has a market cap of 13313.99, and is based in USA. Insider ownership is at 1.10%, and institutional ownership is 91.20%.
At the current price of 80.35, it has a dividend yield of *TBA, and its target price is 77.15. This is with a profit margin of -17.20%, and total debt/equity of 0. Medivation, Inc. (NASDAQ:MDVN) has a P/E of *TBA, as well as a forward P/E of 36.91.
With a current EPS of -1.17, and a forecasted EPS growth for next year at 71.15%,Medivation, Inc. (NASDAQ:MDVN) has had a EPS growth for the past five years at 50.90%. For the next five years EPS growth is projected to be 37.68%.
Performance for the year is 74.54%. Since its IPO date on 1/13/1997, the total performance to date is 66.22%.
Volume today for Medivation, Inc. (NASDAQ:MDVN), is 7540951, while its average volume is 3242.73. Whilst the total gain today was 0.14%, it did have a day high of -0.40%.
Volatility for this week has been at 0.24%, and 1.49% for the month. The 52-week low for Medivation, Inc., MDVN has been 204.24%, while the 52-week-high has reached -0.40%.
Looking at its return of investments, which is 27.10%, and its return on assets is -13.00%. Medivation, Inc. (NASDAQ:MDVN) has an operating margin of -26.30%. With a sales growth of 17.40% quarter over quarter. Bearing in mind that Medivation, Inc., MDVN is in the sector Healthcare, its long-term debt/equity is 0, and has a current ratio of 4.3 and 4.3 for quick ratio.
So what is the value of Medivation, Inc.? Well its PEG is *TBA, and the P/S is 12.96, along with a P/B of 24.8. Meanwhile it has a p/cash of 40.69.